Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01290614 · ClinicalTrials.gov registry record · Phase 4
A Chronic Care Model Based Quality Improvement (QI) Program to Improve the Care of Patients With Chronic Kidney Disease (CKD)
A Phase 4 study of Chronic Kidney Disease, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 4
- Development phase
- 2,199
- Enrollment target
- 1
- Study location
NCT01290614: Completed Phase 4 study of Chronic Kidney Disease, sponsored by University of Minnesota.
NCT01290614 is a Phase 4 study of Chronic Kidney Disease that has completed, run by University of Minnesota. The registered enrollment target is 2,199 participants, below the 3,185-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (31% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01290614, a Phase 4 study of Chronic Kidney Disease, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 2,199 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to evaluate the impact of a chronic care model (CCM) based quality improvement program on 1) outcomes for patients with chronic kidney disease (CKD) and 2) adherence to CKD guidelines. This pilot study will evaluate the feasibility of a CCM based quality improvement program for patients with CKD and assess potential mechanisms for the intervention's effect. Hypothesis: Implementing a CCM based quality improvement program including system level support in the form of collaborative care, a CKD registry, and provider education will 1) reduce systolic BP in patients with poorly controlled hypertension, 2) increase the percentage of patients appropriately monitored for metabolic complications, and 3) decrease the rate of catheter use in patients initiating dialysis.
Primary Outcome
Average SBP for those with a baseline BP \> 130/80
Conditions Studied
Interventions
- OTHER Usual Care
- OTHER Pharmacist based QI program
Study Locations (1)
Ohio
- LSCDVAMC - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,199 participants |
| Start Date | 2011-02 |
| Est. Completion | 2012-06 |
| Phase | Phase 4 |
What the finished NCT01290614 record still lists
NCT01290614 is an interventional study that assigns participants to a tested intervention. Its 2,199 participants enrollment target places it among the larger protocols in the corpus, below the 3,185-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (31% lower).
The record links to 1 condition, with Chronic Kidney Disease appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT01290614 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT01290614 about?
NCT01290614 is a clinical study titled "A Chronic Care Model Based Quality Improvement (QI) Program to Improve the Care of Patients With Chronic Kidney Disease (CKD)". The goal of this study is to evaluate the impact of a chronic care model (CCM) based quality improvement program on 1) outcomes for patients with chronic kidney disease (CKD) and 2) adherence to CKD guidelines. This pilot study will evaluate the feasibility of a CCM based quality improvement program...
What is the current status of trial NCT01290614?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 2,199 participants. The study started on 2011-02. Estimated completion is 2012-06.
What conditions does trial NCT01290614 study?
This clinical trial studies the following conditions: Chronic Kidney Disease.
What interventions are being tested in trial NCT01290614?
The interventions under investigation include: Usual Care (OTHER), Pharmacist based QI program (OTHER).
Who is sponsoring clinical trial NCT01290614?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01290614 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01290614's enrollment target sits among peer trials
2,199 12th of 101 higher than 90 of 101 other Chronic Kidney Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Kidney Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Safety of Short-course of NSAIDs in Pediatric Patients With CKD
RECRUITING · Phase 4
-
L-arginine to Reduce Sympathetic Nerve Activity in CKD Patients
RECRUITING · Phase 4
-
Empagliflozin Treatment in Kidney Transplant Recipients
RECRUITING · Phase 4
-
Trial to Optimize Mineral Outcomes in Dialysis Patients
COMPLETED · Phase 4
-
Phosphate Lowering in CKD Trial
COMPLETED · Phase 4
-
Dialysis Clinical Outcomes Revisited (DCOR) Trial
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05654207 · 2,200 participants · NA
WeCare: A System of Care for Black Youth
- NCT06144554 · 2,200 participants
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
- NCT06526988 · 2,200 participants · NA
Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure
- NCT06682650 · 2,200 participants · NA
Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia